| Melatonin | Dexmedetomidine | Gabapentin | P-value | |
---|---|---|---|---|---|
Clinical variables | Narcotic requirement | 2 (1–3) | 2 (2–3) | 2 (2–2) | 0.457 |
Nausea | 0 (0–1) * | 1 (1–2) | 2 (0–2) | 0.002 | |
Vomiting | 0 (0–1) ** | 1 (1–1) | 1 (0–2) | 0.001 | |
Vital sign change | 0 (0–1) | 0 (0–1) | 0 (0-0.5) | 0.451 | |
Patient satisfaction | Satisfied | 26 (78.8) | 24 (72.7) | 27 (81.8) | 0.193 |
Neutral | 7 (21.2) | 9 (27.3) | 4 (12.1) | ||
Unsatisfied | 0 (0) | 0 (0) | 2 (6.1) | ||
Data are reported as median (IQR) for clinical variables and as frequency (%) for patient satisfaction. *: Melatonin is different with dexmedetomidine (P = 0.004) and gabapentin (P = 0.003). **: Melatonin is different with dexmedetomidine (P = 0.002) and gabapentin (P = 0.001). |